|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
Ƥ������ |
|
���������� |
| ��������������� | |
|
������ |
|
������ |
| PubMed | |
|
Article by |
|
Article by |
������ø-2��Ƥ�������е��о���չ
������, ������
�㽭��ѧҽѧԺ������һҽԺƤ���� ���� 310003
������ø-2��ǰ�����غϳɵ�����ø���о���ʾ������ø-2�Ĺ��ȱ������������ķ�������չ������ء��ͻ�����ø-2�Ľṹ����������ѧ���ԡ�������������չ�Ĺ�ϵ����Ƥ�������е��о���չ����������Ԥ���������е�Ӧ��ǰ������������
[2] Garcia-Rodriguez LA,Huerta-Alvarez C.Reduced risk of colorectal cancer among long-term users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs.Epidemiology,2001,12(1):88-93.
[3] Eli Y,Przedecki F,Levin G,et al.Comparative effects of indomethacin on cell proliferation and cell cycle progression in tumor cells grown in vitro and in vivo.Biochem Pharmacol,2001,61(5):565-571.
[4] Tsujii M,DuBois RN.Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prustaglandin endoperoxide synthase 2.Cell,1995,83(3):493-501.
[5] Marnett LJ.Aspirin and the potential role of prostaglandins in colon cancer.Cancer Res,1992,52(20):5575-5589.
[6] Uefuji K,Ichikura T,Mochizuki H.Cyclooxygenase-2 expression is related to prostaglandin biosynthesis and angiogenesis in human gastric cancer.Clin Cancer Res,2000,6(1):135-138.
[7] Tsujii M,Kawano S,Tsuji S,et al.Cyclooxygenase regulates angiogenesis induced by colon cancer cells.Cell,1998,93(5):705-716.
[8] Masferrer.JL,Leahy KM,Koki AT,et al.Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors.Cancer Res,2000,60(5):1306-1311.
[9] Fosslien E.Molecular pathology of cyclooxygenase-2 in neoplasia.Ann Clin Lab Sci,2000,30(1):3-21.
[10] Muller-Decker K,Reinerth G,Krieg P,et al.Prostaglandin-H-synthase isozyme expression in normal and neoplastic human skin.Int J Cancer,1999,82(5):648-656.
[11] Kagoura M,Toyoda M,Matsui C,et al.Immunohistochemical expression of cyclooxygenase-2 in skin cancers.J Cutan Pathol,2001,28(6):298-302.
[12] Vogt T,McClelland M,Jung B,et al.Progression and NSAID-induced apoptosis in malignant melanomas are independent of cyclooxygenase II.Melanoma Res,2001,11(6):587-599.
[13] Athar M,An KP,Morel KD,et al.Ultraviolet B(UVB)-induced cox-2 expression in murine skin:an immunohistochemical study.Bio-chem Biophys Res Commun,2001,280(4):1042-1047.
[14] Pentland AP,Schoggins JW,Scott GA,et al.Reduction of UV-induced skin tumors in hairless mice by selective COX-2 inhibition.Carcinogenesis,1999,20(10):1939-1944.
[15] Fischer SM,Lo HH,Gordon GB,et al.Chemopreventive activity of celecoxib,a specific cyclooxygenase-2 inhibitor,and indomethacin against ultraviolet light-induced skin earcinogenesis.Mol Careinog,1999,25(4):231-240.
[16] Kim Y,Fischer SM.Transcriptional regulation of cyclooxygenase-2in mouse skin carcinoma cells.Regulatory role of CCAAT/enhancerbinding proteins in the differential expression of cyclooxygenase-2 in normal and neoplastic tissues.J Biol Chem,1998,273(42):27686-27694.
[17] Chen W,Tang Q,Gonzales MS,et al.Role of p38 MAP kinases and ERK in mediating ultraviolet-B induced cyclooxygenase-2 gene expression in human keratinocytes.Oncogene,2001,20(29):3921-3926.
[18] Thompson EJ,Gupta A,Vielhauer GA,et al.The growth of malignant keratinocytes depends on signaling through the PGE(2)receptor EP1.Neoplasia,2001,3(5):402-410.
[19] Marks F,Furstenberger G.Cancer chemoprevention through interruption of multistage carcinogenesis.The lessons learnt by comparing mouse skin carcinogenesis and human large bowel cancer.Eur J Cancer,2000,36(3):314-329.
[20] Higashi Y,Kanekura T,Kanzaki T.Enhanced expression of cyclooxygenase(COX)-2 in human skin epidermal cancer cells:evidence for growth suppression by inhibiting COX-2 expression.Int J Cancer,2000,86(5):667-671.